healthcare
healthcare Articles
Before the coronavirus pandemic is stopped, 25 million more people around the world could become unemployed and up to 35 million could join the ranks of the working poor.
Published:
New cases of COVID-19 jumped by more than 1,200 in one day and some 9 million Americans who work in the leisure and hospitality industry face temporary (or worse) layoffs due to the pandemic.
Published:
Amarin has been right in the middle of this recent market sell-off, and while shares have been halved, the stock could be poised for a strong recovery. All the pieces seem to be there.
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Published:
BioNTech stock jumped on Tuesday and went even higher early on Wednesday. This comes after the company announced a collaboration with the pharmaceutical giant Pfizer.
Published:
Research firm Morning Consult's consumer sentiment index has fallen to a new low again Tuesday as stopping the spread of coronavirus begins to hamper larger chunks of the U.S. economy.
Published:
A recent survey of U.S. adults shows rising concern over the spread of COVID-19 in the United States. Those worries extend to concerns about a possible recession.
Published:
Amazon.com said it has a new demand for 100,000 jobs and will begin to hire immediately. Inevitably, some of these people will be infected by COVID-19. Is the risk worth the reward?
Published:
Aytu Bioscience stock has had investors on a roller-coaster over the past week. The commercial-stage specialty pharmaceutical company has a COVID-19 test kit, but it's not the only one.
Published:
Markets looked like they would be crushed yet again on Monday. 24/7 Wall St. has tracked some stocks that either are defensive in general or were defying Monday’s big drop.
Published:
Tilray chose perhaps the worst time that it could to raise capital, as the prior trading day was the worst one that the markets have seen since the 1987 crash.
Published:
Many investors are becoming extremely worried, and with good reason. But sensible long-term investing has always been the key to financial success. Nothing that has happened in the past month has...
Published:
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Thursday’s big drop because they have some aspect of their business that might be immune to daily scares or...
Published:
Consumer sentiment in the U.S. continues on its downward slide as the impact of the COVID-19 outbreak spreads throughout the nation's economy and many large events are canceled.
Published:
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments...
Published: